Liabilities / Assets
25th percentile
Higher debt load relative to assets than 25% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.01x
Liabilities / Revenue
23rd percentile
Higher debt load relative to revenue than 23% of similar nonprofits.
Net Margin
19th percentile
Higher net margin than 19% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
11th percentile
Faster asset growth than 11% of similar nonprofits.
Revenue Growth
73rd percentile
Faster revenue growth than 73% of similar nonprofits.
Balance Sheet
Assets
Down$2,121,132
Down $298,533 (-12%) from 2011
Net Assets
Down$2,091,054
Down $218,680 (-9.5%) from 2011
Liabilities
Down$30,078
Down $79,853 (-73%) from 2011
Revenue And Expenses
Revenue
Up$1,769,444
Up $244,877 (+16%) from 2011
Expenses
Up$1,988,523
Up $424,485 (+27%) from 2011
Net Income
Down-$219,079
Down $179,608 (-455%) from 2011
Historical Trend
Filing Detail Status
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview
Mission
Cure duchenne is a not-for-profit organization dedicated to coordinating and funding research necessary to find a cure for duchenne muscular dystrophy, increasing public awareness for duchenne muscular dystrophy, and improving their care and health.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $2,121,132
- Liabilities
- $30,078
- Net assets
- $2,091,054
- Revenue
- $1,769,444
- Expenses
- $1,988,523
- Net income
- -$219,079